AI Hardware Shifts From Model Parameters to Real Family Care Scenarios

Summary

The article argues that AI hardware is shifting from competition over models, computing power, and interaction features toward measurable performance in real household scenarios, especially elder care and children’s products. China’s recently described policy and standards signals include coverage of multiple AI terminal categories, support for AI-enabled age-friendly products and rehabilitation equipment, and promotion of smart childcare devices. In elder care, a smart toilet robot showcased at the 2026 Shanghai Senior Expo was priced at 28,999 yuan and had reportedly operated in laboratories, homes, and institutions for about 18 months. Its value is framed around reducing repetitive care work, but the setting also requires reliable transfer, obstacle avoidance, emergency calls, simple controls, dialect recognition, offline use, operation in narrow homes, and dependable maintenance. Children’s AI companion toys may extend hardware revenue through voice interaction, content updates, memory, cloud services, and subscriptions; however, the article says companies have described these businesses as early-stage or small, while privacy, recording, data deletion, age-appropriate content, and parental control remain central concerns. A 2026 national standards series described in the article uses a “2+N” structure and four intelligence levels, from response to tool use, assistance, and collaboration, across categories such as phones, computers, glasses, cars, speakers, and earphones. The standards do not yet cover all care robots and children’s toys, and guidance documents are not equivalent to mandatory safety certification. The article also identifies physical stores and experience centers as important because buyers need to assess comfort, usability, sound, and family acceptance, while noting their installation, training, and service costs. Before mass adoption, products must demonstrate a genuine recurring need, low interaction barriers, credible offline trials, durable after-sales support, and control over recordings, images, and health data. Policy support and product launches alone, it concludes, do not prove mature commercialization; sales, usage, returns, renewal, maintenance, and safety records will be more decisive.